nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.022	0.0961	CbGeAlD
Carbachol—PLA2G4A—cardiovascular system—attention deficit hyperactivity disorder	0.0151	0.0658	CbGeAlD
Carbachol—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0131	0.0573	CbGeAlD
Carbachol—CHRM1—forebrain—attention deficit hyperactivity disorder	0.0119	0.0522	CbGeAlD
Carbachol—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.0119	0.0522	CbGeAlD
Carbachol—PLA2G4A—midbrain—attention deficit hyperactivity disorder	0.0118	0.0514	CbGeAlD
Carbachol—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.0115	0.0502	CbGeAlD
Carbachol—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.0112	0.0491	CbGeAlD
Carbachol—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.0111	0.0485	CbGeAlD
Carbachol—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0107	0.0467	CbGeAlD
Carbachol—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0101	0.0441	CbGeAlD
Carbachol—PLA2G4A—nervous system—attention deficit hyperactivity disorder	0.00967	0.0422	CbGeAlD
Carbachol—PLA2G4A—central nervous system—attention deficit hyperactivity disorder	0.00931	0.0407	CbGeAlD
Carbachol—CHRNA2—brain—attention deficit hyperactivity disorder	0.00913	0.0399	CbGeAlD
Carbachol—PLA2G4A—brain—attention deficit hyperactivity disorder	0.00739	0.0323	CbGeAlD
Carbachol—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00712	0.0311	CbGeAlD
Carbachol—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00686	0.03	CbGeAlD
Carbachol—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00649	0.0283	CbGeAlD
Carbachol—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00624	0.0273	CbGeAlD
Carbachol—CHRM3—nervous system—attention deficit hyperactivity disorder	0.0058	0.0254	CbGeAlD
Carbachol—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00559	0.0244	CbGeAlD
Carbachol—CHRM2—brain—attention deficit hyperactivity disorder	0.00545	0.0238	CbGeAlD
Carbachol—CHRM1—brain—attention deficit hyperactivity disorder	0.00496	0.0217	CbGeAlD
Carbachol—CHRM3—brain—attention deficit hyperactivity disorder	0.00444	0.0194	CbGeAlD
Carbachol—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00131	0.0017	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0013	0.00169	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00127	0.00165	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00165	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00164	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00125	0.00163	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00124	0.00161	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00124	0.00161	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00123	0.0016	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00159	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00123	0.00159	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00119	0.00155	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00116	0.0015	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00149	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00115	0.00149	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00115	0.00149	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00114	0.00148	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00113	0.00147	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00113	0.00146	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00112	0.00145	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00111	0.00143	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00141	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00141	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00107	0.00139	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00107	0.00139	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00107	0.00139	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00107	0.00139	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00107	0.00138	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00106	0.00138	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00106	0.00137	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00106	0.00137	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00104	0.00135	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00104	0.00134	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00103	0.00133	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00133	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00132	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00101	0.00131	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00131	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00101	0.00131	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.001	0.0013	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000997	0.00129	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000992	0.00129	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00099	0.00128	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000986	0.00128	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000977	0.00127	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000972	0.00126	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000971	0.00126	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000968	0.00126	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000959	0.00124	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000955	0.00124	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000941	0.00122	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000938	0.00122	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000928	0.0012	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00092	0.00119	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000917	0.00119	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000908	0.00118	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000891	0.00116	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000888	0.00115	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00088	0.00114	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000876	0.00114	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000873	0.00113	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000865	0.00112	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000865	0.00112	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000862	0.00112	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000862	0.00112	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000859	0.00111	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000854	0.00111	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000852	0.00111	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000851	0.0011	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000849	0.0011	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000806	0.00105	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000803	0.00104	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000795	0.00103	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000766	0.000993	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000762	0.000988	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00076	0.000985	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000754	0.000977	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000751	0.000974	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000745	0.000967	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000744	0.000965	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000739	0.000958	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000736	0.000955	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000718	0.000931	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000715	0.000928	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000708	0.000919	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000703	0.000912	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000701	0.000909	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000701	0.000909	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000698	0.000906	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000694	0.0009	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000692	0.000897	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000679	0.00088	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000676	0.000877	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00067	0.000869	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000667	0.000865	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000665	0.000862	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000659	0.000854	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000659	0.000854	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000658	0.000854	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000657	0.000852	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000657	0.000852	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000652	0.000845	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00065	0.000843	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00065	0.000843	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000649	0.000842	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000644	0.000835	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000643	0.000834	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00064	0.000831	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000638	0.000828	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000636	0.000825	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00063	0.000817	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000627	0.000814	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000615	0.000798	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000614	0.000796	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000612	0.000793	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000606	0.000786	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000598	0.000776	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000579	0.000751	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000574	0.000744	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000572	0.000742	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00057	0.000739	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000566	0.000735	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000564	0.000732	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000563	0.00073	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000562	0.000729	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000557	0.000723	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000529	0.000686	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000529	0.000686	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000524	0.00068	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00052	0.000675	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000515	0.000668	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000487	0.000632	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000486	0.00063	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000484	0.000627	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000481	0.000624	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000459	0.000595	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000448	0.000581	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000447	0.000579	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000442	0.000574	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000442	0.000574	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000441	0.000572	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000437	0.000566	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000435	0.000564	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00043	0.000557	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000428	0.000556	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000426	0.000553	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000426	0.000552	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000425	0.000551	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000424	0.00055	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000423	0.000548	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00042	0.000545	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000402	0.000522	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000396	0.000513	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000395	0.000512	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000391	0.000507	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000387	0.000502	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000386	0.0005	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000385	0.000499	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000384	0.000498	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000383	0.000497	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000382	0.000496	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000382	0.000495	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00038	0.000493	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00038	0.000493	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000379	0.000491	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000377	0.000489	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000377	0.000489	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000376	0.000487	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000376	0.000487	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000372	0.000483	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000372	0.000483	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000372	0.000483	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000371	0.000481	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00037	0.00048	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000369	0.000478	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000367	0.000477	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000367	0.000476	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000365	0.000473	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00036	0.000466	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000358	0.000465	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000355	0.00046	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000353	0.000458	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000348	0.000452	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000347	0.00045	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000347	0.00045	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000346	0.000448	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000344	0.000446	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000342	0.000444	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000342	0.000444	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000342	0.000444	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000341	0.000442	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000339	0.000439	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000338	0.000438	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000438	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000337	0.000437	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000336	0.000436	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000334	0.000433	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000332	0.000431	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—COMT—attention deficit hyperactivity disorder	0.00032	0.000415	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000318	0.000412	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000317	0.000411	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000317	0.000411	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000315	0.000408	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000314	0.000407	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000312	0.000404	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000311	0.000403	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00031	0.000401	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000308	0.0004	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00029	0.000376	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000261	0.000339	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000261	0.000338	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000258	0.000335	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000253	0.000328	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000243	0.000315	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000242	0.000314	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000241	0.000313	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00024	0.000311	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000296	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000295	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000226	0.000292	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000221	0.000286	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00022	0.000285	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000218	0.000282	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000217	0.000281	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000275	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000275	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00021	0.000272	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000206	0.000267	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000205	0.000266	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000203	0.000263	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000262	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000261	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.0002	0.000259	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.0002	0.000259	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000199	0.000258	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000197	0.000256	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000192	0.000249	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000191	0.000247	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000186	0.000241	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000185	0.00024	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000184	0.000238	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000137	0.000178	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000169	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000168	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000129	0.000167	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000115	0.000149	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	8.23e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.9e-05	8.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.88e-05	8.92e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.81e-05	8.84e-05	CbGpPWpGaD
